Evaluation of Gremlin-1 as a therapeutic target in metabolic dysfunction-associated steatohepatitis
P. Horn, J. Norlin, K. Almholt…·P. N. Newsome
This study evaluates Gremlin-1 as a therapeutic target in MASH fibrosis, finding it upregulated but not amenable to targeting due to its restricted expression and lack of effect on fibrogenesis.